Diamante
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $2.7Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2024-09-01attributed |
| Founded | unknown |
| Headquarters | Brazil |
| Industry | biotech |
| Stage | unknown |
| Website | diamantebio.com |
Latin American gene-therapy startup developing programs around durable single-dose treatments. Built around partnered or wholly-owned clinical pipeline. Operates from a Sao Paulo R&D base with academic partnerships.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-09-01 | grant | $2.7M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | diamantebio.com, read 2026-05-02 |
| Description | self-reported | diamantebio.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.